FDA Approve Medtronic Simplera Sync Sensor for AID

The FDA have now approved a version of Medtroinic's Simplera Sync sensor that now pairs with the MiniMed™ 780G insulin pump, marking a major step forward for users of automated insulin delivery systems.

image courtesy of Medtronic Inc.

What's new?

The Simplera Sync isn’t a well-known brand-new name in the CGM space—last summer, Medtronic got FDA approval for the sensor, which was a big leap forward thanks to its slimmer design, and as other CGMs requires no fingerpricks. But what makes this latest approval stand out is its integration, communicating directly with the MiniMed 780G system - Medtronic’s most advanced insulin pump with automated insulin delivery.

For those already familiar with the 780G, you know it includes Meal Detection Technology—a smart algorithm that detects glucose spikes and adjusts insulin delivery, even when you miss a bolus or miscalculate carbs. This new integration with a smaller, more user-friendly CGM sensor is likely to improve both convenience and glucose control.

A closer look at the 780G system

The MiniMed 780G has been a focal point of Medtronic’s efforts to revitalise its diabetes business after facing some regulatory hurdles. With glucose targets that can go as low as 100 mg/dL and smart correction boluses, it’s designed to reduce time spent in hyperglycemia and simplify life for users who are balancing the constant demands of T1D—or potentially even T2D in the near future.

Medtronic is planning a limited release of the Simplera Sync for pump use starting this autumn. In the meantime, they’re also working with Abbott to develop a custom CGM designed exclusively for Medtronic devices. It’s a bold move aimed at strengthening their place in a competitive US market.

---

Thank your for reading. If you have any comments on this blog or the Dexcom G7 15 day wear that would be helpful to other members, please email us - hello@whatcgm.com